Machine learning and cox model-based prediction of CDK4/6 inhibitor outcomes in HR+/HER2 - metastatic breast cancer: a multicenter real-world study.
- DOI
- 10.1007/s10549-026-08019-y
- Published
- 2026 Jul 31
- Container
- Breast cancer research and treatment
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10549-026-08019-y,
title = {Machine learning and cox model-based prediction of CDK4/6 inhibitor outcomes in HR+/HER2 - metastatic breast cancer: a multicenter real-world study.},
author = {Liu B and Wu T and Ding S and Liu X and Zeng X and Liu Z and Lu K and She J and Chen J and Tian H and Tong Q and Tang K and Yu J and Wang J and Ding L and Li Y and Peng L and Zhou Q and Zhou H and Chao T and Ouyang Q and Xie N},
year = {2026},
journal = {Breast cancer research and treatment},
doi = {10.1007/s10549-026-08019-y},
url = {https://doi.org/10.1007/s10549-026-08019-y}
}RIS
TY - JOUR TI - Machine learning and cox model-based prediction of CDK4/6 inhibitor outcomes in HR+/HER2 - metastatic breast cancer: a multicenter real-world study. AU - Liu B AU - Wu T AU - Ding S AU - Liu X AU - Zeng X AU - Liu Z AU - Lu K AU - She J AU - Chen J AU - Tian H AU - Tong Q AU - Tang K AU - Yu J AU - Wang J AU - Ding L AU - Li Y AU - Peng L AU - Zhou Q AU - Zhou H AU - Chao T AU - Ouyang Q AU - Xie N PY - 2026 JO - Breast cancer research and treatment DO - 10.1007/s10549-026-08019-y UR - https://doi.org/10.1007/s10549-026-08019-y ER -
APA
B, L., T, W., S, D., X, L., X, Z., Z, L., K, L., J, S., J, C., H, T., Q, T., K, T., J, Y., J, W., L, D., Y, L., L, P., Q, Z., H, Z., T, C., Q, O., & N, X. (2026). Machine learning and cox model-based prediction of CDK4/6 inhibitor outcomes in HR+/HER2 - metastatic breast cancer: a multicenter real-world study.. Breast cancer research and treatment. https://doi.org/10.1007/s10549-026-08019-y
Source records
- pubmed · retrieved 2026-09-26T14:29:57.461Z